Emerald Advisers’s G1 Therapeutics GTHX Stock Holding History
Bought
Maintained
Sold
Other funds holding GTHX
Emerald Advisers's GTHX Position: Q4 2018 in Review
Emerald Advisers sold out of G1 Therapeutics (GTHX) in Q4 2018, closing a stake of 485,954 shares — an estimated $25.4M sold.
Emerald Advisers first reported a position in GTHX in Q2 2017 and held it in 6 quarters. The position peaked at $26M in Q1 2018. 92 funds tracked by Wall St. Rank hold GTHX as of Q4 2018.
- Emerald Advisers reported no remaining G1 Therapeutics position as of Q4 2018 after selling out during the quarter.
- Emerald Advisers sold 485,954 G1 Therapeutics shares in Q4 2018, an estimated $25.4M.
- Emerald Advisers first reported a position in G1 Therapeutics in Q2 2017 and held it in 6 quarters.
- Emerald Advisers's G1 Therapeutics position peaked at $26M in Q1 2018.
- 92 funds tracked by Wall St. Rank held G1 Therapeutics as of Q4 2018.
Based on Emerald Advisers's 13F filing for Q4 2018, filed 30 Jan 2019.